Levosalbutamol
- Generic Name
- Levosalbutamol
- Brand Names
- Xopenex
- Drug Type
- Small Molecule
- Chemical Formula
- C13H21NO3
- CAS Number
- 34391-04-3
- Unique Ingredient Identifier
- EDN2NBH5SS
- Background
Levosalbutamol, or levalbuterol, is a short-acting β2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
...
- Indication
Indicated for the management of COPD (chronic obstructive pulmonary disease, also known as chronic obstructive lung disease) and asthma.
- Associated Conditions
- Bronchospasm
- Associated Therapies
- -
A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects
- First Posted Date
- 2008-01-02
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 53
- Registration Number
- NCT00583947
Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)
- First Posted Date
- 2008-01-02
- Last Posted Date
- 2011-09-09
- Lead Sponsor
- Phoenix Children's Hospital
- Target Recruit Count
- 101
- Registration Number
- NCT00585039
- Locations
- 🇺🇸
Phoenix Children's Hospital, Phoenix, Arizona, United States
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 386
- Registration Number
- NCT00073840
- Locations
- 🇺🇸
Aeroallergy Research Laboratories of Savannah, Inc., Savannah, Georgia, United States
🇺🇸Rush Presbyterian - St. Luke's Medical Center Rush University, Chicago, Illinois, United States
🇺🇸Research Across America, Dallas, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath